Biosceptre
Manufacturing · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
11 Julius Ave, North Ryde, New South Wal...Phone Number
+44 1223496090Website
www.biosceptre.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Biosceptre
Biosceptre is an innovative company focused on developing targeted therapeutics for cancer patients. They are pioneering a multiple-targeted universal CAR T system, which aims to improve the lives of millions suffering from various malignancies. Their BRiDGECAR system combines nfP2X-targeted CAR T with multiple antibodies, potentially enabling treatment for most cancer types. With several programs targeting both liquid and solid tumors, Biosceptre is dedicated to achieving best-in-class cancer treatments.Explore more
Biosceptre Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Biosceptre your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Biosceptre had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Biosceptre launches new products
Biosceptre, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Biosceptre has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Biosceptre is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Biosceptre
Funding: Get notified immidiatlly once Biosceptre has new funding data
Earning: See what the market has to say on Biosceptre recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Biosceptre as Masked Content
Find 3 more new buyers
Compare Similar Companies to Biosceptre
Compare insights from companies similar to Biosceptre, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Biosceptre is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Biosceptre is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Biosceptre.
Biosceptre financials insights
Gather financial insights about Biosceptre, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Unspecified
$4.7M
2015
Private Equity
$671K
2017
Series A
$10.7M
Biosceptre Tech Stack
A closer look at the technologies used by Biosceptre
See more technologies
Biosceptre News & Media
Initiation of Biosceptre's Phase 1 Clinical Trial for First-in-Class Oncology Vaccine BIL06v
CAMBRIDGE, England, Aug. 21, 2018 /PRNewswire/ -- Biosceptre has initiated its Phase I clinical trial of the peptide vaccine BIL06v, with the first patient treated at the initial trial site on 16th of August 2018. The first patient was recruited at the Sydney Adventist Hospital in Sydney, ...Biosceptre Receives Over £8M in Series A Funding
Biosceptre, a Cambridge, England, UK-based biotech company, received over £8M in series A funding. The round, which will be closed on 21st December, 2017, has seen the participation from Tuspark Science and Technology Service Group, the venture arm of Tsinghua University, Beijing, through its investment vehicle, Bluesky Partnership II L.P. The company intends to use […]PharmaVentures Capital Limited Advises Biosceptre International Limited, a Clinical Stage Oncology Company, on its Series A Private Placement by Tuspark S&T
OXFORD, England, December 15, 2017 /PRNewswire/ -- PharmaVentures Capital Limited is pleased to announce that it acted as adviser to Biosceptre International Limited ("Biosceptre") for the successful Series A private placement from the Chinese conglomerate Tuspark Science &...Biosceptre welcomes Tuspark S & T into its Series A fund raising round
CAMBRIDGE, England, Dec. 14, 2017 /PRNewswire/ -- Biosceptre has received over £8M into its series A raise which will be used to resource the next stage of the companies' development; progression into the clinic of Biosceptre's first systemic products against novel oncology target nfP2X7....
Read more news
Top Manufacturing Companies
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Biosceptre
Sign Up For FreeTo access detailed company insights
Biosceptre is an innovative company focused on developing targeted therapeutics for cancer patients. They are pioneering a multiple-targeted universal CAR T system, which aims to improve the lives of millions suffering from various malignancies. Their BRiDGECAR system combines nfP2X-targeted CAR T with multiple antibodies, potentially enabling trea... Read More
